Corneal Edema
Conditions
Interventions
The 70 patients with eyes affected with acute condition of corneal hydrops who received as routine treatment the conservative form and medication (eyedrops of hypertonic saline solution, antiglaucomat
Sponsors
Universidade Federal de São Paulo
Departamento de Oftalmologia – Unifesp
Eligibility
Age
10 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients older than ten years of age; both genders; patients who were clinically diagnosed with Acute Corneal Hydrops; patients who signed the medical consent term; availability for all the study visits
Exclusion criteria
Exclusion criteria: Having been submitted to ocular surgery in the last six months; presenting Hydrops condition for more than two months; occurrence or suspicion of occurrence of infectious episodes on the ocular surface; presence of Corneal Perforation or Atalamia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected the use of autologous blood to be safer, presenting less cost and discomfort to the patient when compared to the use of C3F8, such as verified by ambulatorial clinical evaluations, from which fewer complications and symptoms were observed. | — |
Secondary
| Measure | Time frame |
|---|---|
| Autologous blood intrastromal injection and C3F8 intracameral injection will accelerate the resolution of the acute corneal hydrops condition, as verified by clinical evaluation and by diagnostic imaging, such as Optical Coherence Tomography, identifying reduction of the corneal edema and the appearance of corneal scaring free of complications. | — |
Countries
Brazil
Contacts
Public ContactJosé Alvaro;Lucas Gomes;Tochetto
Departamento de Oftalmologia – Unifesp;Universidade Federal de São Paulo
Outcome results
None listed